Concepedia

Publication | Open Access

Neratinib Plus Capecitabine Versus Lapatinib Plus Capecitabine in HER2-Positive Metastatic Breast Cancer Previously Treated With ≥ 2 HER2-Directed Regimens: Phase III NALA Trial

DOIFull Paper Access

588

Citations

19

References

2020

Year

Cristina Saura, Mafalda Oliveira, Yin‐Hsun Feng, Ming‐Shen Dai, Shang-Wen Chen, Sara A. Hurvitz, Sung‐Bae Kim, Beverly Moy, Suzette Delaloge, William J. Gradishar,
Journal of Clinical Oncology

Abstract

N+C significantly improved PFS and time to intervention for CNS disease versus L+C. No new N+C safety signals were observed.

References

YearCitations

Page 1